NHS Approves First New Ovarian Cancer Treatment in 20 Years

After two decades without a breakthrough, England's health service has approved a targeted therapy that offers new hope to women with hard-to-treat ovarian cancer.

Around 400 patients annually will now access this "biological missile" treatment that doubles as their first option when chemotherapy stops working.